Skip to content
2000
image of The Impact of Young Age on Breast Cancer Prognosis: A Systematic Review and Meta-Analysis

Abstract

Introduction

There is no consensus on the impact of young age (≤ 35 or 40) on breast cancer prognosis. In this study, a meta-analysis was carried out on the prognosis of breast cancer in young women.

Methods

We searched PubMed, Embase, Web of Science, Cochrane, and key cancer-related international conference proceedings, from their inception to 1st June, 2023, with an update on 15th July, 2023. Studies were included if they reported hazard ratios (HRs) with 95% confidence intervals (CIs) or presented Kaplan–Meier survival curves. The main outcomes were overall survival (OS), disease-free survival (DFS), breast cancer–specific survival (BCSS), local recurrence–free survival (LRFS), distant disease–free survival (DDFS), progression-free survival (PFS), and pathological complete response (pCR). This meta-analysis was registered in PROSPERO (CRD42023459282).

Results

The meta-analysis, including 129 studies with approximately 1,065,000 patients, reported that young breast cancer (YBC) patients had worse OS (HR = 1.30; 95% CI: 1.17 - 1.43; I2 = 93%; P < 0.01), DFS (HR = 1.58; 95% CI: 1.47 - 1.70; I2 = 68%; P < 0.01), BCSS (HR = 1.28; 95% CI: 1·09 - 1.49; I2 = 95%; P < 0.01), LRFS (HR = 2.05; 95% CI: 1.59 - 2.59; I2 = 70%; P < 0.01), DDFS (HR = 1.44; 95% CI: 1.11 - 1.87; I2 = 91%; P < 0.01), and PFS (HR = 1.54; 95% CI: 1.16 - 2·03; I2 = 90%; P < 0.01) and a greater pCR rates than non-young breast cancer (NYBC) patients (odds ratio (OR) = 1.45; 95% CI: 1.16 - 1.82; I2 = 87%; P < 0.01). Subgroup analysis demonstrated that, compared with NYBC patients, certain differences were found in the prognoses of YBC patients with different molecular subtypes, regions, and stages.

Discussion

This meta-analysis confirmed that YBC patients have worse survival outcomes than NYBC patients, despite having higher pCR rates. Subgroup analyses demonstrated that outcomes varied by molecular subtype, region, and disease stage. These findings underscore the importance of early screening, enhanced patient education, and tailored treatment strategies for YBC patients.

Conclusion

Patients with YBC had worse OS, DFS, BCSS, LRFS, DDFS, PFS, and greater pCR rates than NYBC patients.

© 2025 Bentham Science publishers
Loading

Article metrics loading...

/content/journals/ccdt/10.2174/0115680096369006250909091053
2025-09-26
2025-12-13

  • From This Site

    /content/journals/ccdt/10.2174/0115680096369006250909091053
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Sung H. Ferlay J. Siegel R.L. Laversanne M. Soerjomataram I. Jemal A. Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021 71 3 209 249 10.3322/caac.21660 33538338
    [Google Scholar]
  2. Wu J. Fan D. Shao Z. Xu B. Ren G. Jiang Z. Wang Y. Jin F. Zhang J. Zhang Q. Ma F. Ma J. Wang Z. Wang S. Wang X. Wang S. Wang H. Wang T. Wang X. Wang J. Wang J. Wang B. Fu L. Li H. Shi Y. Gan L. Liu Y. Liu J. Liu Z. Liu Q. Sun Q. Cheng W. Yu K. Tong Z. Wu X. Song C. Zhang J. Zhang J. Li J. Li B. Li M. Li H. Yang W. Yang H. Yang B. Bu H. Shen J. Shen Z. Chen Y. Chen C. Pang D. Fan Z. Zheng Y. Yu X. Liu G. Hu X. Ling Y. Tang J. Yin Y. Geng C. Yuan P. Gu Y. Chang C. Cao X. Sheng Y. Huang Y. Huang J. Peng W. Zeng X. Xie Y. Liao N. Daiming F. Zhimin S. Binghe X. Guosheng R. Jiong W. Zefei J. Yongsheng W. Feng J. Jin Z. Qingyuan Z. Fei M. Jinli M. Zhonghua W. Yongsheng W. Shusen W. Xiaojia W. Shu W. Haibo W. Tao W. Xiang W. Jing W. Jia W. Biyun W. Li F. Hongyuan L. Yehui S. Lu G. Guosheng R. Yunjiang L. Jian L. Zhenzhen L. Qiang L. Wenwu C. Zefei J. Keda Y. Zhongsheng T. Xinhong W. Chuangui S. Jianguo Z. Jian Z. Qingyuan Z. Jin Z. Junjie L. Bin L. Man L. Huiping L. Wentao Y. Hongjian Y. Benlong Y. Hong B. Juping S. Zhenzhou S. Zhimin S. Yiding C. Ceshi C. Da P. Zhimin F. Ying Z. Feng J. Xiaoli Y. Guangyu L. Xichun H. Yiqun L. Jinhai T. Binghe X. Yongmei Y. Cuizhi G. Cuizhi G. Cuizhi G. Peng Y. Yajia G. Cai C. Xuchen C. Yuan S. Yuanxi H. Jian H. Jian H. Weijun P. Xiaohua Z. Yuntao X. Ning L. CACA guidelines for holistic integrative management of breast cancer. Holist Integr Oncol. 2022 1 1 7 10.1007/s44178‑022‑00007‑8 37520336
    [Google Scholar]
  3. Bonadio R.C. Moreira O.A. Testa L. Breast cancer trends in women younger than 40 years in Brazil. Cancer Epidemiol. 2022 78 102139 10.1016/j.canep.2022.102139 35290906
    [Google Scholar]
  4. Colonna M. Delafosse P. Uhry Z. Poncet F. Arveux P. Molinie F. Cherie-Challine L. Grosclaude P. Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983–2002. Breast 2008 17 3 289 292 10.1016/j.breast.2007.10.017 18053721
    [Google Scholar]
  5. Heer E. Ruan Y. Mealey N. Quan M.L. Brenner D.R. The incidence of breast cancer in Canada 1971–2015: Trends in screening-eligible and young-onset age groups. Can. J. Public Health 2020 111 5 787 793 10.17269/s41997‑020‑00305‑6 32144720
    [Google Scholar]
  6. Leclère B. Molinié F. Trétarre B. Stracci F. Daubisse-Marliac L. Colonna M. Trends in incidence of breast cancer among women under 40 in seven European countries: A GRELL cooperative study. Cancer Epidemiol. 2013 37 5 544 549 10.1016/j.canep.2013.05.001 23768969
    [Google Scholar]
  7. Wang H. Tsai Y.H. Dong Y.H. Liu J.J. Young adult cancer incidence trends in Taiwan and the U.S. from 2002 to 2016. Cancer Epidemiol. 2022 78 102144 10.1016/j.canep.2022.102144 35334356
    [Google Scholar]
  8. Wang X Xia C C Landscape of young breast cancer under 35 years in China over the past decades: A multicentre retrospective cohort study (YBCC-Catts study). eClinicalMed 2023 64 102243 10.1016/j.eclinm.2023.102243 37936654
    [Google Scholar]
  9. Harbeck N. Penault-Llorca F. Cortes J. Gnant M. Houssami N. Poortmans P. Ruddy K. Tsang J. Cardoso F. Breast cancer. Nat. Rev. Dis. Primers 2019 5 1 66 10.1038/s41572‑019‑0111‑2 31548545
    [Google Scholar]
  10. Loibl S. Poortmans P. Morrow M. Denkert C. Curigliano G. Breast cancer. Lancet 2021 397 10286 1750 1769 10.1016/S0140‑6736(20)32381‑3 33812473
    [Google Scholar]
  11. Trayes K.P. Cokenakes S.E.H. Breast cancer treatment. Am. Fam. Physician 2021 104 2 171 178 [PMID: 34383430
    [Google Scholar]
  12. Lohmann A.E. Soldera S.V. Pimentel I. Ribnikar D. Ennis M. Amir E. Goodwin P.J. Association of obesity with breast cancer outcome in relation to cancer subtypes: A meta-analysis. J. Natl. Cancer Inst. 2021 113 11 1465 1475 10.1093/jnci/djab023 33620467
    [Google Scholar]
  13. Chan D.S.M. Vieira A.R. Aune D. Bandera E.V. Greenwood D.C. McTiernan A. Navarro Rosenblatt D. Thune I. Vieira R. Norat T. Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies. Ann. Oncol. 2014 25 10 1901 1914 10.1093/annonc/mdu042 24769692
    [Google Scholar]
  14. Amadou A. Ferrari P. Muwonge R. Moskal A. Biessy C. Romieu I. Hainaut P. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: A systematic review and dose‐response meta‐analysis. Obes. Rev. 2013 14 8 665 678 10.1111/obr.12028 23615120
    [Google Scholar]
  15. Beadle B.M. Woodward W.A. Buchholz T.A. The impact of age on outcome in early-stage breast cancer. Semin. Radiat. Oncol. 2011 21 1 26 34 10.1016/j.semradonc.2010.09.001 21134651
    [Google Scholar]
  16. Freedman R.A. Partridge A.H. Management of breast cancer in very young women. Breast 2013 22 S176 S179 (Suppl. 2)
    [Google Scholar]
  17. Dubsky P.C. Gnant M.F.X. Taucher S. Roka S. Kandioler D. Pichler-Gebhard B. Agstner I. Seifert M. Sevelda P. Jakesz R. Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer. Clin. Breast Cancer 2002 3 1 65 72 10.3816/CBC.2002.n.013 12020397
    [Google Scholar]
  18. Bonnier P. Romain S. Charpin C. Lejeune C. Tubiana N. Martin P.M. Piana L. Age as a prognostic factor in breast cancer: Relationship to pathologic and biologic features. Int. J. Cancer 1995 62 2 138 144 10.1002/ijc.2910620205 7622286
    [Google Scholar]
  19. Chung M. Chang H.R. Bland K.I. Wanebo H.J. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 1996 77 1 97 103 10.1002/(SICI)1097‑0142(19960101)77:1<97:AID‑CNCR16>3.0.CO;2‑3 8630946
    [Google Scholar]
  20. de la Rochefordière A. Campana F. Fenton J. Vilcoq J.R. Fourquet A. Asselain B. Scholl S.M. Pouillart P. Durand J-C. Magdelenat H. Age as prognostic factor in premenopausal breast carcinoma. Lancet 1993 341 8852 1039 1043 10.1016/0140‑6736(93)92407‑K 8096955
    [Google Scholar]
  21. Marubini E. Mezzanotte G. Boracchi P. Veronesi U. Long term survival analysis: Breast cancer and age at diagnosis. Stat. Med. 1990 9 7 737 748 10.1002/sim.4780090704 2218177
    [Google Scholar]
  22. Richards M.A. Smith P. Fentiman I.S. Gregory W.M. Millis R.R. Rubens R.D. Age as prognostic factor in premenopausal breast cancer. Lancet 1993 341 8858 1484 1485 10.1016/0140‑6736(93)90932‑7 8099185
    [Google Scholar]
  23. Sant M. Capocaccia R. Verdecchia A. Estève J. Gatta G. Micheli A. Coleman M.P. Berrino F. Survival of women with breast cancer in Europe: Variation with age, year of diagnosis and country. Int. J. Cancer 1998 77 5 679 683 10.1002/(SICI)1097‑0215(19980831)77:5<679:AID‑IJC3>3.0.CO;2‑S 9688298
    [Google Scholar]
  24. Radecka B. Litwiniuk M. Breast cancer in young women. Ginekol. Pol. 2016 87 9 659 663 10.5603/GP.2016.0062 27723074
    [Google Scholar]
  25. Co M. Kwong A. Young onset breast cancer in Southern China – a 5-year clinico-pathological study from a multi-centre database. Can-cer Treat Res. Commun, 2020 24 100182 10.1016/j.ctarc.2020.100182 32534410
    [Google Scholar]
  26. Yang Y. Wei W. Jin L. He H. Wei M. Shen S. Pi H. Liu Z. Li H. Liu J. Comparison of the characteristics and prognosis between very young women and older women with breast cancer: A multi-institutional report from China. Front. Oncol. 2022 12 783487 10.3389/fonc.2022.783487 35280812
    [Google Scholar]
  27. Warner E.T. Colditz G.A. Palmer J.R. Partridge A.H. Rosner B.A. Tamimi R.M. Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: Are there differences before and after age 40? Breast Cancer Res. Treat. 2013 142 1 165 175 10.1007/s10549‑013‑2721‑9 24136668
    [Google Scholar]
  28. Chollet-Hinton L. Anders C.K. Tse C.K. Bell M.B. Yang Y.C. Carey L.A. Olshan A.F. Troester M.A. Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: A case-control study. Breast Cancer Res. 2016 18 1 79 10.1186/s13058‑016‑0736‑y 27492244
    [Google Scholar]
  29. Chen H. Zhou M. Tian W. Meng K. He H. Effect of age on breast cancer patient prognoses: A population-based study using the SEER 18 database. PLoS One 2016 11 10 e0165409 10.1371/journal.pone.0165409 27798652
    [Google Scholar]
  30. Malone K.E. Daling J.R. Neal C. Suter N.M. O’Brien C. Cushing-Haugen K. Jonasdottir T.J. Thompson J.D. Ostrander E.A. Frequency ofBRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 2000 88 6 1393 1402 10.1002/(SICI)1097‑0142(20000315)88:6<1393:AID‑CNCR17>3.0.CO;2‑P 10717622
    [Google Scholar]
  31. Paluch-Shimon S. Cardoso F. Partridge A.H. Abulkhair O. Azim H.A. Bianchi-Micheli G. Cardoso M.J. Curigliano G. Gelmon K.A. Gentilini O. Harbeck N. Kaufman B. Kim S.B. Liu Q. Merschdorf J. Poortmans P. Pruneri G. Senkus E. Sirohi B. Spanic T. Sulosaari V. Peccatori F. Pagani O. ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5). Ann. Oncol. 2022 33 11 1097 1118 10.1016/j.annonc.2022.07.007 35934170
    [Google Scholar]
  32. Bhatia S. Pappo A.S. Acquazzino M. Allen-Rhoades W.A. Barnett M. Borinstein S.C. Casey R. Choo S. Chugh R. Dinner S. Ermoian R. Fair D. Federman N. Folbrecht J. Gandhi S. Germann J. Goldsby R. Hayashi R. Huang A.Y. Huang M.S. Jacobs L.A. Lee-Miller C. Link M.P. Livingston J.A. Lustberg M. Malogolowkin M. Oeffinger K.C. Pratilas C.A. Reed D. Skiles J. von Mehren M. Yeager N. Montgomery S. Hang L. Adolescent and young adult (AYA) oncology, version 2.2024, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 2023 21 8 851 880 10.6004/jnccn.2023.0040 37549914
    [Google Scholar]
  33. Wu J. Lu A.D. Zhang L.P. Zuo Y.X. Jia Y.P. Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi 2019 40 1 52 57 10.3760/cma.j.issn.0253‑2727.2019.01.010 30704229
    [Google Scholar]
  34. Basmadjian R.B. Chow K. Kim D. Kenney M. Lukmanji A. O’Sullivan D.E. Xu Y. Quan M.L. Cheung W.Y. Lupichuk S. Brenner D.R. The association between early-onset diagnosis and clinical outcomes in triple-negative breast cancer: A systematic review and meta-analysis. Cancers 2023 15 7 1923 10.3390/cancers15071923 37046584
    [Google Scholar]
  35. Alieldin N.H. Abo-Elazm O.M. Bilal D. Salem S.E. Gouda E. Elmongy M. Ibrahim A.S. Age at diagnosis in women with non-metastatic breast cancer: Is it related to prognosis? J. Egypt. Natl. Canc. Inst. 2014 26 1 23 30 10.1016/j.jnci.2013.08.005 24565679
    [Google Scholar]
  36. Foo C.S. Su D. Chong C.K. Chng H.C. Tay K.H. Low S.C. Tan S.M. Breast cancer in young Asian women: Study on survival. ANZ J. Surg. 2005 75 7 566 572 10.1111/j.1445‑2197.2005.03431.x 15972049
    [Google Scholar]
  37. Varga D. Wischnewsky M. Atassi Z. Wolters R. Geyer V. Strunz K. Kreienberg R. Woeckel A. Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients? Oncology 2010 78 3-4 189 195 10.1159/000313698 20414007
    [Google Scholar]
  38. Holli K. Isola J. Effect of age on the survival of breast cancer patients. Eur. J. Cancer 1997 33 3 425 428 10.1016/S0959‑8049(97)89017‑X 9155527
    [Google Scholar]
  39. Yadav B.S. Das D. Bansal A. Dahiya D. Hypofractionated radiotherapy in young versus older women with breast cancer: A retrospective study from India. Rep. Pract. Oncol. Radiother. 2022 27 2 281 290 10.5603/RPOR.a2022.0028 36299397
    [Google Scholar]
  40. Release notice - Canadian Cancer Statistics 2019. Health Promot. Chronic Dis. Prev. Can. 2019 39 8-9 255 10.24095/hpcdp.39.8/9.04 31517469
    [Google Scholar]
  41. DeSantis C.E. Ma J. Gaudet M.M. Newman L.A. Miller K.D. Goding Sauer A. Jemal A. Siegel R.L. Breast cancer statistics, 2019. CA Cancer J. Clin. 2019 69 6 438 451 10.3322/caac.21583 31577379
    [Google Scholar]
  42. Page M.J. McKenzie J.E. Bossuyt P.M. Boutron I. Hoffmann T.C. Mulrow C.D. Shamseer L. Tetzlaff J.M. Akl E.A. Brennan S.E. Chou R. Glanville J. Grimshaw J.M. Hróbjartsson A. Lalu M.M. Li T. Loder E.W. Mayo-Wilson E. McDonald S. McGuinness L.A. Stewart L.A. Thomas J. Tricco A.C. Welch V.A. Whiting P. Moher D. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021 372 71 n71 10.1136/bmj.n71 33782057
    [Google Scholar]
  43. Liu N. Zhou Y. Lee J.J. IPDfromKM: Reconstruct individual patient data from published Kaplan-Meier survival curves. BMC Med. Res. Methodol. 2021 21 1 111 10.1186/s12874‑021‑01308‑8 34074267
    [Google Scholar]
  44. Wells G. Wells G. Shea B. Shea B. O’Connell D. Peterson J. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014 Available from: [https://www.semanticscholar.org/paper/The-Newcastle-Ottawa-Scale-(NOS)-for-Assessing-the-Wells-Wells/c293fb316b6176154c3fdbb8340a107d9c8c82bf
    [Google Scholar]
  45. Egger M. Smith G.D. Schneider M. Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997 315 7109 629 634 10.1136/bmj.315.7109.629 9310563
    [Google Scholar]
  46. Sterne J.A.C. Sutton A.J. Ioannidis J.P.A. Terrin N. Jones D.R. Lau J. Carpenter J. Rücker G. Harbord R.M. Schmid C.H. Tetzlaff J. Deeks J.J. Peters J. Macaskill P. Schwarzer G. Duval S. Altman D.G. Moher D. Higgins J.P.T. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011 343(jul22 1) d4002 10.1136/bmj.d4002 21784880
    [Google Scholar]
  47. Tan K.F. Adam F. Hussin H. Mohd Mujar N.M. A comparison of breast cancer survival across different age groups: A multicentric database study in Penang, Malaysia. Epidemiol. Health 2021 43 e2021038 10.4178/epih.e2021038 34044478
    [Google Scholar]
  48. Szollár A. Újhelyi M. Polgár C. Oláh E. Pukancsik D. Rubovszky G. Udvarhelyi N. Kovács T. Sávolt Á. Kenessey I. Mátrai Z. A long-term retrospective comparative study of the oncological outcomes of 598 very young (≤35 years) and young (36–45 years) breast cancer patients. Eur. J. Surg. Oncol. 2019 45 11 2009 2015 10.1016/j.ejso.2019.06.007 31189512
    [Google Scholar]
  49. Kwon J. Eom K.Y. Koo T.R. Kim B.H. Kang E. Kim S.W. Kim Y.J. Park S.Y. Kim I.A. A prognostic model for patients with triple-negative breast cancer: Importance of the modified nottingham prognostic index and age. J. Breast Cancer 2017 20 1 65 73 10.4048/jbc.2017.20.1.65 28382096
    [Google Scholar]
  50. Solin L.J. Goodman R.L. Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1989 16 2 373 381 10.1016/0360‑3016(89)90333‑7 2537806
    [Google Scholar]
  51. Barchielli A. Balzi D. Age at diagnosis, extent of disease and breast cancer survival: A population-based study in Florence, Italy. Tumori 2000 86 2 119 123 10.1177/030089160008600202 10855847
    [Google Scholar]
  52. Walsh S.M. Zabor E.C. Flynn J. Stempel M. Morrow M. Gemignani M.L. Breast cancer in young black women. Br. J. Surg. 2020 107 6 677 686 10.1002/bjs.11401 31981221
    [Google Scholar]
  53. Gillett D. Kennedy C. Carmalt H. Breast cancer in young women. Aust. N. Z. J. Surg. 1997 67 11 761 764 10.1111/j.1445‑2197.1997.tb04575.x 9396990
    [Google Scholar]
  54. Wei X.Q. Li X. Xin X.J. Tong Z.S. Zhang S. Asian Pac. J. Cancer Prev. 2013 14 10 5949 5952 10.7314/APJCP.2013.14.10.5949 24289606
    [Google Scholar]
  55. Abulkhair O. Moghraby J.S. Badri M. Alkushi A. Clinicopathologic features and prognosis of triple-negative breast cancer in patients 40 years of age and younger in Saudi Arabia. Hematol. Oncol. Stem Cell Ther. 2012 5 2 101 106 10.5144/1658‑3876.2012.101 22828374
    [Google Scholar]
  56. Sun X. Liu J. Ji H. Yang M. Lu Y. Clinicopathological characteristics and prognosis of breast cancer in young women – A single center study in a developing country. Cancer Manag. Res. 2021 13 1601 1607 10.2147/CMAR.S299066 33628050
    [Google Scholar]
  57. Wei J.T. Huang W.H. Du C.W. Qiu S.Q. Wei X.L. Liu J. Zhang G.J. Clinicopathological features and prognostic factors of young breast cancers in Eastern Guangdong of China. Sci. Rep. 2014 4 1 5360 10.1038/srep05360 24942640
    [Google Scholar]
  58. Tang J. Wu C.C. Xie Z.M. Luo R.Z. Yang M.T. Comparison of clinical features and treatment outcome of breast cancers in young and elderly chinese patients. Breast Care 2011 6 6 435 440 10.1159/000332593 22419896
    [Google Scholar]
  59. Varga D. Koenig J. Kuhr K. Strunz K. Geyer V. Kurzeder C. Atassi Z. Blettner M. Kreienberg R. Woeckel A. Comparison of early onset breast cancer patients to older premenopausal breast cancer patients. Arch. Gynecol. Obstet. 2010 282 4 427 432 10.1007/s00404‑009‑1339‑y 20047053
    [Google Scholar]
  60. Pruessmann J. Pursche T. Hammersen F. Katalinic A. Fischer D. Waldmann A. Conditional disease-free and overall survival of 1,858 young women with non-metastatic breast cancer and with participation in a post-therapeutic rehab programme according to clinical subtypes. Breast Care 2021 16 2 163 172 10.1159/000507315 34012371
    [Google Scholar]
  61. Abdel-Razeq H. Iweir S. Abdel-Razeq R. Rahman F.A. Almasri H. Bater R. Taqash A. Abdelkhaleq H. Differences in clinicopathological characteristics, treatment, and survival outcomes between older and younger breast cancer patients. Sci. Rep. 2021 11 1 14340 10.1038/s41598‑021‑93676‑w 34253800
    [Google Scholar]
  62. Ryu J.M. Yu J. Kim S.I. Kim K.S. Moon H.G. Choi J.E. Jeong J. Do Byun K. Nam S.J. Lee J.E. Lee S.K. Kim S.W. Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: A nationwide study from the Korean Breast Cancer Society. Breast Cancer Res. Treat. 2017 166 3 833 842 10.1007/s10549‑017‑4472‑5 28831642
    [Google Scholar]
  63. Maggard M.A. O’Connell J.B. Lane K.E. Liu J.H. Etzioni D.A. Ko C.Y. Do young breast cancer patients have worse outcomes? J. Surg. Res. 2003 113 1 109 113 10.1016/S0022‑4804(03)00179‑3 12943818
    [Google Scholar]
  64. Dufour O. Houvenaeghel G. Classe J.M. Cohen M. Faure C. Mazouni C. Chauvet M.P. Jouve E. Darai E. Azuar A.S. Gimbergues P. Gonçalves A. de Nonneville A. Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysis. Breast 2023 68 163 172 10.1016/j.breast.2023.02.004 36774756
    [Google Scholar]
  65. Kollias J. Elston C.W. Ellis I.O. Robertson J.F.R. Blamey R.W. Early-onset breast cancer – histopathological and prognostic considerations. Br. J. Cancer 1997 75 9 1318 1323 10.1038/bjc.1997.223 9155052
    [Google Scholar]
  66. Partridge A.H. Gelber S. Piccart-Gebhart M.J. Focant F. Scullion M. Holmes E. Winer E.P. Gelber R.D. Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: Results from a herceptin adjuvant trial. J. Clin. Oncol. 2013 31 21 2692 2698 10.1200/JCO.2012.44.1956 23752109
    [Google Scholar]
  67. El Saghir N.S. Seoud M. Khalil M.K. Charafeddine M. Salem Z.K. Geara F.B. Shamseddine A.I. Effects of young age at presentation on survival in breast cancer. BMC Cancer 2006 6 1 194 10.1186/1471‑2407‑6‑194 16857060
    [Google Scholar]
  68. Gnerlich J. Deshpande A.D. Jeffe D.B. Sweet A. White N. Margenthaler J.A. J. Am. Coll. Surg. 2008 207 3 S79 10.1016/j.jamcollsurg.2008.06.196
    [Google Scholar]
  69. De Camargo Cancela M. Comber H. Sharp L.H.R. +/Her2- breast cancer in pre-menopausal women: The impact of younger age on clinical characteristics at diagnosis, disease management and survival. Cancer Epidemiol. 2016 45 162 168 10.1016/j.canep.2016.10.019 27846443
    [Google Scholar]
  70. Frank S. Carton M. Dubot C. Campone M. Pistilli B. Dalenc F. Mailliez A. Levy C. D’Hondt V. Debled M. Vermeulin T. Coudert B. Perrin C. Gonçalves A. Uwer L. Ferrero J.M. Eymard J.C. Petit T. Mouret-Reynier M.A. Patsouris A. Guesmia T. Bachelot T. Robain M. Cottu P. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort. Breast 2020 52 50 57 10.1016/j.breast.2020.04.009 32380440
    [Google Scholar]
  71. Keegan T.H.M. Press D.J. Tao L. DeRouen M.C. Kurian A.W. Clarke C.A. Gomez S.L. Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women. Breast Cancer Res. 2013 15 5 R95 10.1186/bcr3556 24131591
    [Google Scholar]
  72. Saifi O. Chahrour M.A. Li Z. Hoballah J. Panoff J. Vallow L.A. Zeidan Y.H. Is breast conservation superior to mastectomy in early stage triple negative breast cancer? Breast 2022 62 144 151 10.1016/j.breast.2022.02.006 35182994
    [Google Scholar]
  73. Aebi S. Gelber S. Castiglione-Gertsch M. Gelber R.D. Collins J. Thürlimann B. Rudenstam C.M. Lindtner J. Crivellari D. Cortes-Funes H. Simoncini E. Werner I.D. Coates A.S. Goldhirsch A. Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet 2000 355 9218 1869 1874 10.1016/S0140‑6736(00)02292‑3 10866443
    [Google Scholar]
  74. Jayasinghe U.W. Taylor R. Boyages J.I.S. Is age at diagnosis an independent prognostic factor for survival following breast cancer? ANZ J. Surg. 2005 75 9 762 767 10.1111/j.1445‑2197.2005.03515.x 16173989
    [Google Scholar]
  75. Yang H. Ou W. Sun H. Fang Q. Wu Y. Wang S. Is tamoxifen alone adequate therapy in very young Chinese women with operable breast cancer? Breast J. 2012 18 2 124 129 10.1111/j.1524‑4741.2011.01202.x 22236200
    [Google Scholar]
  76. Rudra S. Yu D.S. Yu E.S. Switchenko J.M. Mister D. Torres M.A. Locoregional and distant recurrence patterns in young versus elderly women treated for breast cancer. Int. J. Breast Cancer 2015 2015 1 9 10.1155/2015/213123 25949828
    [Google Scholar]
  77. Tang L.C. Jin X. Yang H.Y. He M. Chang H. Shao Z.M. Di G.H. Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China. BMC Cancer 2015 15 1 201 10.1186/s12885‑015‑1207‑z 25885213
    [Google Scholar]
  78. Zhang W. Wu S. Liu J. Zhang X. Ma X. Yang C. Cao M. Zhang S. Liu Y. Metastasis patterns and prognosis in young breast cancer patients: A SEER database analysis. Front. Oncol. 2022 12 872862 10.3389/fonc.2022.872862 36313697
    [Google Scholar]
  79. Tjokrowidjaja A. Lee C.K. Houssami N. Lord S. Metastatic breast cancer in young women: A population‐based cohort study to describe risk and prognosis. Intern. Med. J. 2014 44 8 764 770 10.1111/imj.12481 24863750
    [Google Scholar]
  80. Villarreal-Garza C. Mohar A. Bargallo-Rocha J.E. Lasa-Gonsebatt F. Reynoso-Noverón N. Matus-Santos J. Cabrera P. Arce-Salinas C. Lara-Medina F. Alvarado-Miranda A. Ramírez-Ugalde M.T. Soto-Perez-de-Celis E. Molecular subtypes and prognosis in young mexican women with breast cancer. Clin. Breast Cancer 2017 17 3 e95 e102 10.1016/j.clbc.2016.11.007 28065398
    [Google Scholar]
  81. Braud A.C. Asselain B. Scholl S. De La Rochefordière A. Palangie T. Dieras V. Pierga J.Y. Dorval T. Jouve M. Beuzeboc P. Pouillart P. Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse? Eur. J. Cancer 1999 35 3 392 397 10.1016/S0959‑8049(98)00393‑1 10448288
    [Google Scholar]
  82. von Waldenfels G. Loibl S. Furlanetto J. Machleidt A. Lederer B. Denkert C. Hanusch C. Kümmel S. von Minckwitz G. Schneeweiss A. Untch M. Rhiem K. Fasching P.A. Blohmer J.U. Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - A pooled analysis of individual patient data from eight prospectively randomized controlled trials. Oncotarget 2018 9 20 15168 15179 10.18632/oncotarget.24586 29632634
    [Google Scholar]
  83. Loibl S. Jackisch C. Lederer B. Untch M. Paepke S. Kümmel S. Schneeweiss A. Huober J. Hilfrich J. Hanusch C. Gerber B. Eidtmann H. Denkert C. Costa S.D. Blohmer J.U. Nekljudova V. Mehta K. von Minckwitz G. Outcome after neoadjuvant chemotherapy in young breast cancer patients: A pooled analysis of individual patient data from eight prospectively randomized controlled trials. Breast Cancer Res. Treat. 2015 152 2 377 387 10.1007/s10549‑015‑3479‑z 26109347
    [Google Scholar]
  84. Peng R. Wang S. Shi Y. Liu D. Teng X. Qin T. Zeng Y. Yuan Z. Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: A retrospective matched case–control study. Breast 2011 20 6 568 573 10.1016/j.breast.2011.07.012 21843944
    [Google Scholar]
  85. Ahn S.H. Son B.H. Kim S.W. Kim S.I. Jeong J. Ko S.S. Han W. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: Nationwide survival data in Korea--A report from the Korean Breast Cancer Society. J. Clin. Oncol. 2007 25 17 2360 2368 10.1200/JCO.2006.10.3754 17515570
    [Google Scholar]
  86. Park Y.H. Lee S.J. Jung H.A. Kim S.M. Kim M.J. Kil W.H. Lee J.E. Nam S.J. Ahn J.S. Im Y.H. Prevalence and clinical outcomes of young breast cancer (YBC) patients according to intrinsic breast cancer subtypes: Single institutional experience in Korea. Breast 2015 24 3 213 217 10.1016/j.breast.2015.01.012 25728283
    [Google Scholar]
  87. Cancello G. Maisonneuve P. Rotmensz N. Viale G. Mastropasqua M.G. Pruneri G. Veronesi P. Torrisi R. Montagna E. Luini A. Intra M. Gentilini O. Ghisini R. Goldhirsch A. Colleoni M. Ann. Oncol. 2010 21 10 1974 1981 10.1093/annonc/mdq072 20332136
    [Google Scholar]
  88. Liu Y. Xin T. Huang D. Shen W. Li L. Lv Y. Jin Y. Song X. Teng C. Jiang Q. Prognosis in very young women with triple-negative breast cancer: retrospective study of 216 cases. Med. Oncol. 2014 31 12 222 10.1007/s12032‑014‑0222‑2 25391919
    [Google Scholar]
  89. Yoshida M. Shimizu C. Fukutomi T. Tsuda H. Kinoshita T. Akashi-Tanaka S. Ando M. Hojo T. Fujiwara Y. Prognostic factors in young Japanese women with breast cancer: Prognostic value of age at diagnosis. Jpn. J. Clin. Oncol. 2011 41 2 180 189 10.1093/jjco/hyq191 20947623
    [Google Scholar]
  90. Kim E.K. Noh W.C. Han W. Noh D.Y. World J. Surg. 2011 35 6 1244 1253 10.1007/s00268‑011‑1071‑1 21472372
    [Google Scholar]
  91. Li X. Dai D. Chen B. He S. Zhang J. Wen C. Wang B. Prognostic values of preoperative serum CEA And CA125 levels and nomograms for young breast cancer patients. OncoTargets Ther. 2019 12 8789 8800 10.2147/OTT.S221335 31695434
    [Google Scholar]
  92. Yao Y. Chu Y. Xu B. Hu Q. Song Q. Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer. Cancer Med. 2019 8 2 554 563 10.1002/cam4.1954 30632300
    [Google Scholar]
  93. Mallet A. Lusque A. Levy C. Pistilli B. Brain E. Pasquier D. Debled M. Thery J.C. Gonçalves A. Desmoulins I. De La Motte Rouge T. Faure C. Ferrero J.M. Eymard J.C. Mouret-Reynier M.A. Patsouris A. Cottu P. Dalenc F. Petit T. Payen O. Uwer L. Guiu S. Frenel J.S. Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancer. Ther. Adv. Med. Oncol. 2022 14 17588359211070362 10.1177/17588359211070362 35082924
    [Google Scholar]
  94. Villarreal-Garza C. Bargallo-Rocha J.E. Soto-Perez-de-Celis E. Lasa-Gonsebatt F. Arce-Salinas C. Lara-Medina F. Reynoso-Noverón N. Matus-Santos J. Cabrera P. Alvarado-Miranda A. Mohar A. Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy. Breast Cancer Res. Treat. 2016 157 2 385 394 10.1007/s10549‑016‑3811‑2 27189008
    [Google Scholar]
  95. Han W. Kang S.Y. Relationship between age at diagnosis and outcome of premenopausal breast cancer: Age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res. Treat. 2010 119 1 193 200 10.1007/s10549‑009‑0388‑z 19350387
    [Google Scholar]
  96. Nixon A.J. Neuberg D. Hayes D.F. Gelman R. Connolly J.L. Schnitt S. Abner A. Recht A. Vicini F. Harris J.R. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J. Clin. Oncol. 1994 12 5 888 894 10.1200/JCO.1994.12.5.888 8164038
    [Google Scholar]
  97. De Lima Vazquez F. Silva T.B. Da Costa Vieira R.A. Da Costa A.M. Scapulatempo C. Fregnani J.H.T.G. Mauad E.C. Longatto A. Syrjänen K.J. Retrospective analysis of breast cancer prognosis among young and older women in a Brazilian cohort of 738 patients, 1985–2002. Oncol. Lett. 2016 12 6 4911 4924 10.3892/ol.2016.5360 28101229
    [Google Scholar]
  98. Colleoni M. Rotmensz N. Peruzzotti G. Maisonneuve P. Orlando L. Ghisini R. Viale G. Pruneri G. Veronesi P. Luini A. Intra M. Cardillo A. Torrisi R. Rocca A. Goldhirsch A. Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann. Oncol. 2006 17 10 1497 1503 10.1093/annonc/mdl145 16798834
    [Google Scholar]
  99. Eng L.G. Dawood S. Sopik V. Haaland B. Tan P.S. Bhoo-Pathy N. Warner E. Iqbal J. Narod S.A. Dent R. Ten-year survival in women with primary stage IV breast cancer. Breast Cancer Res. Treat. 2016 160 1 145 152 10.1007/s10549‑016‑3974‑x 27628191
    [Google Scholar]
  100. Terman E. Sheade J. Zhao F. Howard F.M. Jaskowiak N. Tseng J. Chen N. Hahn O. Fleming G. Huo D. Nanda R. The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer. Breast Cancer Res. Treat. 2023 200 1 75 83 10.1007/s10549‑023‑06943‑x 37120458
    [Google Scholar]
  101. Hariharan N. Rao T.S. Naidu C.K. Raju K.V.V.N. Rajappa S. Ayyagari S. Krishnamohan M.V.T. Murthy S. Suryadevara A. Boleneni N. The impact of stage and molecular subtypes on survival outcomes in young women with breast cancer. J. Adolesc. Young Adult Oncol. 2019 8 5 628 634 10.1089/jayao.2019.0023 31259658
    [Google Scholar]
  102. Chung W.P. Lee K.T. Chen Y.P. Hsu Y.T. Loh Z.J. Huang C.C. Hsu H.P. The prognosis of early-stage breast cancer in extremely young female patients. Medicine 2021 100 1 e24076 10.1097/MD.0000000000024076 33429771
    [Google Scholar]
  103. Dai D. Zhong Y. Wang Z. Yousafzai N.A. Jin H. Wang X. The prognostic impact of age in different molecular subtypes of breast cancer: A population-based study. PeerJ 2019 7 e7252 10.7717/peerj.7252 31309004
    [Google Scholar]
  104. Liedtke C. Hess K.R. Karn T. Rody A. Kiesel L. Hortobagyi G.N. Pusztai L. Gonzalez-Angulo A.M. The prognostic impact of age in patients with triple-negative breast cancer. Breast Cancer Res. Treat. 2013 138 2 591 599 10.1007/s10549‑013‑2461‑x 23460246
    [Google Scholar]
  105. Ordu C. McGuire K. Alco G. Nur Pilanci K. Koksal U.I. Elbüken F. The prognostic impact of molecular subtypes and very young age on breast conserving surgery in early stage breast cancer. Cureus 2016 8 6 e633 10.7759/cureus.633 27433412
    [Google Scholar]
  106. Yousefi Kashi A.S. Yazdanfar S. Akbari M.E. Rakhsha A. Triple negative breast cancer in Iranian women: Clinical profile and survival study. Int. J. Cancer Manag. 2017 10 8 e10471 10.5812/ijcm.10471
    [Google Scholar]
  107. Lee J.A. Kim K.I. Bae J.W. Jung Y.H. An H. Lee E.S. Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival. Breast Cancer Res. Treat. 2010 123 1 177 187 10.1007/s10549‑010‑0998‑5 20574671
    [Google Scholar]
  108. Sarsenov D. Ilgun S. Ordu C. Alco G. Bozdogan A. Elbuken F. True local recurrences after breast conserving surgery have poor prognosis in patients with early breast cancer. Cureus 2016 8 3 e541 10.7759/cureus.541 27158571
    [Google Scholar]
  109. Tang L.C. Yin W.J. Di G.H. Shen Z.Z. Shao Z.M. Unfavourable clinicopathologic features and low response rate to systemic adjuvant therapy: Results with regard to poor survival in young Chinese breast cancer patients. Breast Cancer Res. Treat. 2010 122 1 95 104 10.1007/s10549‑009‑0537‑4 19760032
    [Google Scholar]
  110. Kim S.H. Simkovich-Heerdt A. Tran K.N. Maclean B. Borgen P.I. Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. J. Am. Coll. Surg. 1998 187 1 1 8 10.1016/S1072‑7515(98)00114‑8 9660018
    [Google Scholar]
  111. Kataoka A. Iwamoto T. Tokunaga E. Tomotaki A. Kumamaru H. Miyata H. Niikura N. Kawai M. Anan K. Hayashi N. Masuda S. Tsugawa K. Aogi K. Ishida T. Masuoka H. Iijima K. Kinoshita T. Nakamura S. Tokuda Y. Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: A study from the Japanese Breast Cancer Registry. Breast Cancer Res. Treat. 2016 160 1 163 172 10.1007/s10549‑016‑3984‑8 27647460
    [Google Scholar]
  112. Love R.R. Ba Duc N. Van Dinh N. Tu Quy T. Xin Y. Havighurst T.C. Young age as an adverse prognostic factor in premenopausal women with operable breast cancer. Clin. Breast Cancer 2002 2 4 294 298 10.3816/CBC.2002.n.005 11899361
    [Google Scholar]
  113. Han W. Kim S.W. Ae Park I. Kang D. Kim S.W. Youn Y.K. Oh S.K. Choe K.J. Noh D.Y. Young age: An independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 2004 4 1 82 10.1186/1471‑2407‑4‑82 15546499
    [Google Scholar]
  114. Wang J. Wang J. Li Q. Zhang P. Yuan P. Ma F. Luo Y. Cai R. Fan Y. Chen S. Li Q. Xu B. Young breast cancer patients who develop distant metastasis after surgery have better survival outcomes compared with elderly counterparts. Oncotarget 2017 8 27 44851 44859 10.18632/oncotarget.15268 28206957
    [Google Scholar]
  115. Aaltomaa S. Lipponen P. Papinaho S. Young breast-cancer patients have unfavorable prognosis because of biologically aggressive tumors. Int. J. Oncol. 1993 2 2 331 334 10.3892/ijo.2.2.331 21573559
    [Google Scholar]
  116. Kheirelseid E.A.H. Boggs J.M.E. Curran C. Glynn R.W. Dooley C. Sweeney K.J. Kerin M.J. Younger age as a prognostic indicator in breast cancer: A cohort study. BMC Cancer 2011 11 1 383 10.1186/1471‑2407‑11‑383 21871129
    [Google Scholar]
  117. Tzikas A.K. Nemes S. Linderholm B.K. A comparison between young and old patients with triple-negative breast cancer: Biology, survival and metastatic patterns. Breast Cancer Res. Treat. 2020 182 3 643 654 10.1007/s10549‑020‑05727‑x 32524352
    [Google Scholar]
  118. de Nonneville A. Gonçalves A. Zemmour C. Cohen M. Classe J.M. Reyal F. Colombo P.E. Jouve E. Giard S. Barranger E. Sabatier R. Bertucci F. Boher J.M. Houvenaeghel G. Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study. Eur. J. Cancer 2017 84 34 43 10.1016/j.ejca.2017.06.043 28780480
    [Google Scholar]
  119. Zhang L. Hao C. Dong G. Tong Z. Analysis of clinical features and outcome of 356 triple-negative breast cancer patients in China. Breast Care 2012 7 1 13 17 10.1159/000336539 22553467
    [Google Scholar]
  120. Kim J. Hong S. Lee J.J. Won Y.J. Lee E.S. Kang H.S. Lee S. Han J.H. Lee E.G. Jo H. Kim H.H. Jung S.Y. Analysis of the tumor characteristics in young age breast cancer patients using collaborative stage data of the Korea Central Cancer Registry. Breast Cancer Res. Treat. 2021 187 3 785 792 10.1007/s10549‑021‑06107‑9 33604714
    [Google Scholar]
  121. Elkum N. Dermime S. Ajarim D. Al-Zahrani A. Alsayed A. Tulbah A. Al Malik O. Alshabanah M. Ezzat A. Al-Tweigeri T. Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience. BMC Cancer 2007 7 1 222 10.1186/1471‑2407‑7‑222 18053234
    [Google Scholar]
  122. Acevedo F. Camus M. Sanchez C. Breast cancer at extreme ages--A comparative analysis in Chile. Asian Pac. J. Cancer Prev. 2015 16 4 1455 1461 10.7314/APJCP.2015.16.4.1455 25743815
    [Google Scholar]
  123. Sheridan W. Scott T. Caroline S. Yvonne Z. Vanessa B. David V. Karen G. Stephen C. Breast cancer in young women: Have the prognostic implications of breast cancer subtypes changed over time? Breast Cancer Res. Treat. 2014 147 3 617 629 10.1007/s10549‑014‑3125‑1 25209005
    [Google Scholar]
  124. Bao S. He G. Comparing the prognoses of breast-conserving surgeries for differently aged women with early stage breast cancer: Use of a propensity score method. Breast J. 2022 2022 1801717 10.1155/2022/1801717 35711900
    [Google Scholar]
  125. Wang L. He Y. Li J. Wang T. Xie Y. Fan Z. Ouyang T. Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: Long-term results using propensity score adjustment method. Breast Cancer Res. Treat. 2020 183 3 717 728 10.1007/s10549‑020‑05821‑0 32715444
    [Google Scholar]
  126. Lin C.H. Chuang P.Y. Chiang C.J. Lu Y.S. Cheng A.L. Kuo W.H. Huang C.S. Lai M.S. You S.L. Tang C.H. Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: A nationwide cancer registry-based study. Oncologist 2014 19 6 583 591 10.1634/theoncologist.2014‑0047 24807917
    [Google Scholar]
  127. Kim J.K. Kwak B.S. Lee J.S. Hong S.J. Kim H.J. Son B.H. Ahn S.H. Do very young Korean breast cancer patients have worse outcomes? Ann. Surg. Oncol. 2007 14 12 3385 3391 10.1245/s10434‑006‑9345‑9 17899295
    [Google Scholar]
  128. Zhong W. Tan L. Jiang W.G. Chen K. You N. Sanders A.J. Liang G. Liu Z. Ling Y. Gong C. Effect of younger age on survival outcomes in T1N0M0 breast cancer: A propensity score matching analysis. J. Surg. Oncol. 2019 119 8 1039 1046 10.1002/jso.25457 30892719
    [Google Scholar]
  129. Azim H.A. Michiels S. Bedard P.L. Singhal S.K. Criscitiello C. Ignatiadis M. Haibe-Kains B. Piccart M.J. Sotiriou C. Loi S. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin. Cancer Res. 2012 18 5 1341 1351 10.1158/1078‑0432.CCR‑11‑2599 22261811
    [Google Scholar]
  130. Lambertini M. Fielding S. Loibl S. Janni W. Clark E. Franzoi M.A. Fumagalli D. Caballero C. Arecco L. Salomoni S. Ponde N.F. Poggio F. Kim H.J. Villarreal-Garza C. Pagani O. Paluch-Shimon S. Ballestrero A. Del Mastro L. Piccart M. Bines J. Partridge A.H. de Azambuja E. Impact of age on clinical outcomes and efficacy of adjuvant dual Anti-HER2 targeted therapy. J. Natl. Cancer Inst. 2022 114 8 1117 1126 10.1093/jnci/djac096 35512402
    [Google Scholar]
  131. Cheng S.H.C. Yu B.L. Horng C.F. Tsai S.Y. Chen C.M. Chu N.M. Tsou M-H. Lin C.K.J. Shih L-S. Liu M-C. Long-term survival and stage I breast cancer subtypes. J. Cancer Res. Pract 2016 3 1 1 8 10.1016/j.jcrpr.2015.10.005
    [Google Scholar]
  132. Wang M.X. Ren J.T. Tang L.Y. Ren Z.F. Molecular features in young vs elderly breast cancer patients and the impacts on survival disparities by age at diagnosis. Cancer Med. 2018 7 7 3269 3277 10.1002/cam4.1544 29761914
    [Google Scholar]
  133. Zenzola V. Cabezas-Quintario M.A. Arguelles M. Pérez-Fernández E. Izarzugaza Y. Correa A. García-Foncillas J. Prognostic value of Ki-67 according to age in patients with triple-negative breast cancer. Clin. Transl. Oncol. 2018 20 11 1448 1454 10.1007/s12094‑018‑1877‑5 29671222
    [Google Scholar]
  134. Yoon T.I. Hwang U.K. Kim E.T. Lee S. Sohn G. Ko B.S. Lee J.W. Son B.H. Kim S. Ahn S.H. Kim H.J. Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy. Breast Cancer Res. Treat. 2017 165 2 311 320 10.1007/s10549‑017‑4331‑4 28601930
    [Google Scholar]
  135. Rhee J. Han S.W. Oh D.Y. Kim J.H. Im, S.A.; Han, W.; Ae Park, I.; Noh, D.Y.; Bang, Y.J.; Kim, T.Y. The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer. BMC Cancer 2008 8 1 307 10.1186/1471‑2407‑8‑307 18947390
    [Google Scholar]
  136. Kim N.H. Bang H.W. Eom Y.H. Choi S.H. The different prognostic impact of age according to individual molecular subtypes in breast cancer. Ann. Surg. Treat. Res. 2022 103 3 129 144 10.4174/astr.2022.103.3.129 36128031
    [Google Scholar]
  137. Lee M.K. Varzi L.A. Chung D.U. Cao M. Gornbein J. Apple S.K. Chang H.R. The effect of young age in hormone receptor positive breast cancer. BioMed Res. Int. 2015 2015 1 6 10.1155/2015/325715 26351632
    [Google Scholar]
  138. Jobsen J.J. van der Palen J. Meerwaldt J.H. The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy. Eur. J. Cancer 2001 37 15 1820 1827 10.1016/S0959‑8049(01)00173‑3 11576834
    [Google Scholar]
  139. Bouferraa Y. Haibe Y. Chedid A. Jabra E. Charafeddine M. Temraz S. Mukherji D. El Saghir N. Shamseddine A. BMC Cancer 2022 22 1 27 10.1186/s12885‑021‑09100‑z 34980002
    [Google Scholar]
  140. Lian W. Fu F. Lin Y. Lu M. Chen B. Yang P. Zeng B. Huang M. Wang C. The impact of young age for prognosis by subtype in women with early breast cancer. Sci. Rep. 2017 7 1 11625 10.1038/s41598‑017‑10414‑x 28912475
    [Google Scholar]
  141. Anders C.K. Hsu D.S. Broadwater G. Acharya C.R. Foekens J.A. Zhang Y. Wang Y. Marcom P.K. Marks J.R. Febbo P.G. Nevins J.R. Potti A. Blackwell K.L. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J. Clin. Oncol. 2008 26 20 3324 3330 10.1200/JCO.2007.14.2471 18612148
    [Google Scholar]
  142. Liu Z. Sahli Z. Wang Y. Wolff A.C. Cope L.M. Umbricht C.B. Young age at diagnosis is associated with worse prognosis in the Luminal A breast cancer subtype: A retrospective institutional cohort study. Breast Cancer Res. Treat. 2018 172 3 689 702 10.1007/s10549‑018‑4950‑4 30225619
    [Google Scholar]
  143. El Chediak A. Alameddine R. Hakim A. Hilal L. Abdel Massih S. Hamieh L. Mukherji D. Temraz S. Charafeddine M. Shamseddine A. Younger age is an independent predictor of worse prognosis among Lebanese nonmetastatic breast cancer patients: Analysis of a prospective cohort. Breast Cancer 2017 9 407 414 10.2147/BCTT.S130273 28670139
    [Google Scholar]
  144. Fredholm H. Eaker S. Frisell J. Holmberg L. Fredriksson I. Lindman H. Breast cancer in young women: Poor survival despite intensive treatment. PLoS One 2009 4 11 e7695 10.1371/journal.pone.0007695 19907646
    [Google Scholar]
  145. Johansson A.L.V. Trewin C.B. Hjerkind K.V. Ellingjord-Dale M. Johannesen T.B. Ursin G. Breast cancer‐specific survival by clinical subtype after 7 years follow‐up of young and elderly women in a nationwide cohort. Int. J. Cancer 2019 144 6 1251 1261 10.1002/ijc.31950 30367449
    [Google Scholar]
  146. Fu J. Wu L. Fu W. Tan Y. Xu T. Hong Z. Wang F. Li S. How young is too young in breast cancer?—Young breast cancer is not a unique biological subtype. Clin. Breast Cancer 2018 18 1 e25 e39 10.1016/j.clbc.2017.05.015 28802528
    [Google Scholar]
  147. Murthy R.K. Song J. Raghavendra A.S. Li Y. Hsu L. Hess K.R. Barcenas C.H. Valero V. Carlson R.W. Tripathy D. Hortobagyi G.N. Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice. NPJ Breast Cancer 2020 6 1 11 10.1038/s41523‑020‑0152‑4 32219153
    [Google Scholar]
  148. Fredholm H. Magnusson K. Lindström L.S. Garmo H. Fält S.E. Lindman H. Bergh J. Holmberg L. Pontén F. Frisell J. Fredriksson I. Long-term outcome in young women with breast cancer: A population-based study. Breast Cancer Res. Treat. 2016 160 1 131 143 10.1007/s10549‑016‑3983‑9 27624330
    [Google Scholar]
  149. Ihemelandu C.U. Leffall L.D. Dewitty R.L. Naab T.J. Mezghebe H.M. Makambi K.H. Adams-Campbell L. Frederick W.A. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: Age-specific prevalence and survival. J. Surg. Res. 2007 143 1 109 118 10.1016/j.jss.2007.03.085 17950079
    [Google Scholar]
  150. Bharat A. Aft R.L. Gao F. Margenthaler J.A. Patient and tumor characteristics associated with increased mortality in young women (≤40 years) with breast cancer. J. Surg. Oncol. 2009 100 3 248 251 10.1002/jso.21268 19330813
    [Google Scholar]
  151. Karihtala P. Jääskeläinen A. Roininen N. Jukkola A. Real-world, single-centre prospective data of age at breast cancer onset: Focus on survival and reproductive history. BMJ Open 2021 11 1 e041706 10.1136/bmjopen‑2020‑041706 33518519
    [Google Scholar]
  152. Partridge A.H. Hughes M.E. Warner E.T. Ottesen R.A. Wong Y.N. Edge S.B. Theriault R.L. Blayney D.W. Niland J.C. Winer E.P. Weeks J.C. Tamimi R.M. Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J. Clin. Oncol. 2016 34 27 3308 3314 10.1200/JCO.2015.65.8013 27480155
    [Google Scholar]
  153. Kim H.J. Kim S. Freedman R.A. Partridge A.H. Breast 2022 61 77 83 10.1016/j.breast.2021.12.006 34923225
    [Google Scholar]
  154. Zhang X. Yang J. Cai H. Ye Y. Young age is an independent adverse prognostic factor in early stage breast cancer: A population-based study. Cancer Manag. Res. 2018 10 4005 4018 10.2147/CMAR.S167363 30310322
    [Google Scholar]
  155. Radosa J.C. Eaton A. Stempel M. Khander A. Liedtke C. Solomayer E.F. Karsten M. Pilewskie M. Morrow M. King T.A. Evaluation of local and distant recurrence patterns in patients with triple-negative breast cancer according to age. Ann. Surg. Oncol. 2017 24 3 698 704 10.1245/s10434‑016‑5631‑3 27783163
    [Google Scholar]
  156. Lai S.F. Chen Y.H. Kuo W.H. Lien H.C. Wang M.Y. Lu Y.S. Lo C. Kuo S.H. Cheng A.L. Huang C.S. Locoregional recurrence risk for postmastectomy breast cancer patients with T1–2 and one to three positive lymph nodes receiving modern systemic treatment without radiotherapy. Ann. Surg. Oncol. 2016 23 12 3860 3869 10.1245/s10434‑016‑5435‑5 27436202
    [Google Scholar]
  157. Burkbauer L. Goldbach M. Hoffman D.I. Giannakou A. Dultz R. Brooks A.D. Sataloff D.M. Keele L. Tchou J. Preoperative MRI and its impact on surgical outcomes in patients with triple negative breast cancer treated with primary surgery: Did new margin guidelines or cavity shave margins practice diminish the role of preoperative MRI? Ann. Surg. Oncol. 2022 29 7 4079 4088 10.1245/s10434‑022‑11545‑w 35303180
    [Google Scholar]
  158. Kim S.W. Chun M. Han S. Jung Y.S. Choi J.H. Kang S.Y. Yim H. Kang S.H. Young age is associated with increased locoregional recurrence in node-positive breast cancer with luminal subtypes. Cancer Res. Treat. 2017 49 2 484 493 10.4143/crt.2016.246 27554479
    [Google Scholar]
  159. Fredholm H. Magnusson K. Lindström L.S. Tobin N.P. Lindman H. Bergh J. Holmberg L. Pontén F. Frisell J. Fredriksson I. Breast cancer in young women and prognosis: How important are proliferation markers? Eur. J. Cancer 2017 84 278 289 10.1016/j.ejca.2017.07.044 28844016
    [Google Scholar]
  160. Gajdos C. Tartter P.I. Bleiweiss I.J. Bodian C. Brower S.T. Stage 0 to stage III breast cancer in young women1. J. Am. Coll. Surg. 2000 190 5 523 529 10.1016/S1072‑7515(00)00257‑X 10801018
    [Google Scholar]
  161. Franco I. Alshalalfa M. Hernandez A. Mahal B.A. Nguyen T. Wang L. Punglia R. Swami N. Goel N. Genomic characterization of aggressive breast cancer in younger women. Ann. Surg. Oncol. 2023 30 12 7569 7578 10.1245/s10434‑023‑14080‑4 37550448
    [Google Scholar]
  162. Anwar S.L. Raharjo C.A. Herviastuti R. Dwianingsih E.K. Setyoheriyanto D. Avanti W.S. Choridah L. Harahap W.A. Darwito; Aryandono, T.; Wulaningsih, W. Pathological profiles and clinical management challenges of breast cancer emerging in young women in Indonesia: A hospital-based study. BMC Womens Health 2019 19 1 28 10.1186/s12905‑019‑0724‑3 30728000
    [Google Scholar]
  163. Huober J. von Minckwitz G. Denkert C. Tesch H. Weiss E. Zahm D.M. Belau A. Khandan F. Hauschild M. Thomssen C. Högel B. Darb-Esfahani S. Mehta K. Loibl S. Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: Overall results from the GeparTrio study. Breast Cancer Res. Treat. 2010 124 1 133 140 10.1007/s10549‑010‑1103‑9 20697801
    [Google Scholar]
  164. de Paula B.H.R. Kumar S. Morosini F.M. Calábria Cardoso D.E.M. de Sousa C.A.M. Crocamo S. Real-world assessment of the effect of impact of tumor size on pathological complete response rates in triple negative breast cancer after neoadjuvant chemotherapy. Chin Clin. Oncol 2020 9 6 78 78 10.21037/cco‑20‑111 33183012
    [Google Scholar]
  165. Verdial F.C. Mamtani A. Pawloski K.R. Sevilimedu V. D’Alfonso T.M. Zhang H. Gemignani M.L. Barrio A.V. Morrow M. Tadros A.B. The effect of age on outcomes after neoadjuvant chemotherapy for breast cancer. Ann. Surg. Oncol. 2022 29 6 3810 3819 10.1245/s10434‑022‑11367‑w 35246810
    [Google Scholar]
  166. Li Y. Chen H. He J. Fan Z. Zhang H. The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012). Front. Public Health 2023 11 1100421 10.3389/fpubh.2023.1100421 36895689
    [Google Scholar]
  167. Assi H.A. Khoury K.E. Dbouk H. Khalil L.E. Mouhieddine T.H. El Saghir N.S. Epidemiology and prognosis of breast cancer in young women. J. Thorac Dis 2013 5 (Suppl 1) S2 S8 (Suppl 1) 23819024
    [Google Scholar]
  168. Foulkes W.D. Inherited susceptibility to common cancers. N. Engl. J. Med. 2008 359 20 2143 2153 10.1056/NEJMra0802968 19005198
    [Google Scholar]
  169. Partridge A.H. Wang P.S. Winer E.P. Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J. Clin. Oncol. 2003 21 4 602 606 10.1200/JCO.2003.07.071 12586795
    [Google Scholar]
  170. Huiart L. Ferdynus C. Giorgi R. A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: Summarizing the data for clinicians. Breast Cancer Res. Treat. 2013 138 1 325 328 10.1007/s10549‑013‑2422‑4 23400580
    [Google Scholar]
  171. Hershman D.L. Kushi L.H. Shao T. Buono D. Kershenbaum A. Tsai W.Y. Fehrenbacher L. Lin Gomez S. Miles S. Neugut A.I. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J. Clin. Oncol. 2010 28 27 4120 4128 10.1200/JCO.2009.25.9655 20585090
    [Google Scholar]
  172. Kaufmann M. von Minckwitz G. Bear H.D. Buzdar A. McGale P. Bonnefoi H. Colleoni M. Denkert C. Eiermann W. Jackesz R. Makris A. Miller W. Pierga J.Y. Semiglazov V. Schneeweiss A. Souchon R. Stearns V. Untch M. Loibl S. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: New perspectives 2006. Ann. Oncol. 2007 18 12 1927 1934 10.1093/annonc/mdm201 17998286
    [Google Scholar]
  173. Gralow J.R. Burstein H.J. Wood W. Hortobagyi G.N. Gianni L. von Minckwitz G. Buzdar A.U. Smith I.E. Symmans W.F. Singh B. Winer E.P. Preoperative therapy in invasive breast cancer: Pathologic assessment and systemic therapy issues in operable disease. J. Clin. Oncol. 2008 26 5 814 819 10.1200/JCO.2007.15.3510 18258991
    [Google Scholar]
  174. Zhu J.W. Charkhchi P. Adekunte S. Akbari M.R. What is known about breast cancer in young women? Cancers 2023 15 6 1917 10.3390/cancers15061917 36980802
    [Google Scholar]
  175. Conte B. Soldato D. Razeti M.G. Fregatti P. de Azambuja E. Schettini F. Prat A. Del Mastro L. Lambertini M. De novo metastatic breast cancer arising in young women: Review of the current evidence. Clin. Breast Cancer 2022 22 1 78 87 10.1016/j.clbc.2021.10.001 34750070
    [Google Scholar]
  176. Krop I.E. Kim S.B. Martin A.G. LoRusso P.M. Ferrero J.M. Badovinac-Crnjevic T. Hoersch S. Smitt M. Wildiers H. Trastuzumab emtansine versus treatment of physician’s choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): Final overall survival results from a randomised open-label phase 3 trial. Lancet Oncol. 2017 18 6 743 754 10.1016/S1470‑2045(17)30313‑3 28526538
    [Google Scholar]
  177. Paris S. Tarantini L. Navazio A. Faggiano P. Cardio-oncology: The new frontier of clinical and preventive cardiology. Monaldi Arch. Chest Dis. 2020 90 2 90 10.4081/monaldi.2020.1348 32571000
    [Google Scholar]
  178. Bauer K.R. Brown M. Cress R.D. Parise C.A. Caggiano V. Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype. Cancer 2007 109 9 1721 1728 10.1002/cncr.22618 17387718
    [Google Scholar]
  179. Dent R. Trudeau M. Pritchard K.I. Hanna W.M. Kahn H.K. Sawka C.A. Lickley L.A. Rawlinson E. Sun P. Narod S.A. Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin. Cancer Res. 2007 13 15 4429 4434 10.1158/1078‑0432.CCR‑06‑3045 17671126
    [Google Scholar]
  180. Haffty B.G. Yang Q. Reiss M. Kearney T. Higgins S.A. Weidhaas J. Harris L. Hait W. Toppmeyer D. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J. Clin. Oncol. 2006 24 36 5652 5657 10.1200/JCO.2006.06.5664 17116942
    [Google Scholar]
  181. Carey L.A. Perou C.M. Livasy C.A. Dressler L.G. Cowan D. Conway K. Karaca G. Troester M.A. Tse C.K. Edmiston S. Deming S.L. Geradts J. Cheang M.C.U. Nielsen T.O. Moorman P.G. Earp H.S. Millikan R.C. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006 295 21 2492 2502 10.1001/jama.295.21.2492 16757721
    [Google Scholar]
  182. Jagtap S. Evaluation of CD4+ T-cells and CD8+ T-cells in triple-negative invasive breast cancer. Indian J. Pathol. Microbiol. 2018 61 4 477 478 10.4103/IJPM.IJPM_201_18 30303132
    [Google Scholar]
  183. Gonzalez-Angulo A.M. Timms K.M. Liu S. Chen H. Litton J.K. Potter J. Lanchbury J.S. Stemke-Hale K. Hennessy B.T. Arun B.K. Hortobagyi G.N. Do K.A. Mills G.B. Meric-Bernstam F. Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin. Cancer Res. 2011 17 5 1082 1089 10.1158/1078‑0432.CCR‑10‑2560 21233401
    [Google Scholar]
  184. Lakhani S.R. van de Vijver M.J. Jacquemier J. Anderson T.J. Osin P.P. McGuffog L. Easton D.F. The pathology of familial breast cancer: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J. Clin. Oncol. 2002 20 9 2310 2318 10.1200/JCO.2002.09.023 11981002
    [Google Scholar]
  185. Liu M. Xie F. Liu M. Zhang Y. Wang S. Association between BRCA mutational status and survival in patients with breast cancer: A systematic review and meta-analysis. Breast Cancer Res. Treat. 2021 186 3 591 605 10.1007/s10549‑021‑06104‑y 33559780
    [Google Scholar]
  186. Di Nardo P. Lisanti C. Garutti M. Buriolla S. Alberti M. Mazzeo R. Puglisi F. Chemotherapy in patients with early breast cancer: Clinical overview and management of long-term side effects. Expert Opin. Drug Saf. 2022 21 11 1341 1355 10.1080/14740338.2022.2151584 36469577
    [Google Scholar]
  187. Mandó P. Waisberg F. Pasquinelli R. Rivero S. Ostinelli A. Perazzo F. HER2-directed therapy in advanced breast cancer: Benefits and risks. OncoTargets Ther. 2023 16 115 132 10.2147/OTT.S335934 36844609
    [Google Scholar]
  188. Perez E.A. Dang C. Lee C. Singh J. Wang K. Layton J.B. Gilsenan A. Hackshaw M.D. Cortes J. Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: A literature review. Breast Cancer Res. Treat. 2022 194 1 1 11 10.1007/s10549‑021‑06469‑0 35587323
    [Google Scholar]
  189. Geisel J. Raghu M. Hooley R. The role of ultrasound in breast cancer screening: The case for and against ultrasound. Semin. Ultrasound CT MR 2018 39 1 25 34 10.1053/j.sult.2017.09.006 29317037
    [Google Scholar]
  190. Boyd N.F. Guo H. Martin L.J. Sun L. Stone J. Fishell E. Jong R.A. Hislop G. Chiarelli A. Minkin S. Yaffe M.J. Mammographic density and the risk and detection of breast cancer. N. Engl. J. Med. 2007 356 3 227 236 10.1056/NEJMoa062790 17229950
    [Google Scholar]
  191. Brem R.F. Lenihan M.J. Lieberman J. Torrente J. Screening breast ultrasound: Past, present, and future. AJR Am. J. Roentgenol. 2015 204 2 234 240 10.2214/AJR.13.12072 25615743
    [Google Scholar]
  192. Pan J.W. Zabidi M.M.A. Ng P.S. Meng M.Y. Hasan S.N. Sandey B. Sammut S.J. Yip C.H. Rajadurai P. Rueda O.M. Caldas C. Chin S.F. Teo S.H. The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences. Nat. Commun. 2020 11 1 6433 10.1038/s41467‑020‑20173‑5 33353943
    [Google Scholar]
  193. Zheng S. Bai J.Q. Li J. Fan J.H. Pang Y. Song Q.K. Huang R. Yang H.J. Xu F. Lu N. Qiao Y.L. The pathologic characteristics of breast cancer in China and its shift during 1999–2008: A national‐wide multicenter cross‐sectional image over 10 years. Int. J. Cancer 2012 131 11 2622 2631 10.1002/ijc.27513 22377956
    [Google Scholar]
  194. Lan B. Ma F. Chen S. Wang W. Li Q. Fan Y. Luo Y. Cai R. Wang J. Yuan P. Zhang P. Li Q. Xu B. Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10T/T genotype breast cancer patients in China. Int. J. Cancer 2018 143 10 2499 2504 10.1002/ijc.31639 29978573
    [Google Scholar]
  195. Yap Y.S. Lu Y.S. Tamura K. Lee J.E. Ko E.Y. Park Y.H. Cao A.Y. Lin C.H. Toi M. Wu J. Lee S.C. Insights into breast cancer in the east vs the west. JAMA Oncol. 2019 5 10 1489 1496 10.1001/jamaoncol.2019.0620 31095268
    [Google Scholar]
  196. Yang Y. Liu J. Peng M. Su F. Xie X. Liu Z. Wu J. Wei W. Zhou D. Li W. Zhang A. Su G. Yang W. Chen J. Ma D. Cai Y. Chen K. Zhu L. Liu Q. Song E. Introduction of a multicenter online database for non-metastatic breast cancer in China. Sci. China Life Sci. 2020 63 9 1417 1420 10.1007/s11427‑019‑1625‑1 32088826
    [Google Scholar]
  197. Fan L. Strasser-Weippl K. Li J.J. St Louis J. Finkelstein D.M. Yu K.D. Chen W.Q. Shao Z.M. Goss P.E. Breast cancer in China. Lancet Oncol. 2014 15 7 e279 e289 10.1016/S1470‑2045(13)70567‑9 24872111
    [Google Scholar]
  198. De la Cruz Ku G. Karamchandani M. Chambergo-Michilot D. Narvaez-Rojas A.R. Jonczyk M. Príncipe-Meneses F.S. Posawatz D. Nardello S. Chatterjee A. Does breast-conserving surgery with radiotherapy have a better survival than mastectomy? A meta-analysis of more than 1,500,000 patients. Ann. Surg. Oncol. 2022 29 10 6163 6188 10.1245/s10434‑022‑12133‑8 35876923
    [Google Scholar]
  199. Liu G. Kong X. Dai Q. Cheng H. Wang J. Gao J. Wang Y. Clinical features and prognoses of patients with breast cancer who underwent surgery. JAMA Netw. Open 2023 6 8 e2331078 10.1001/jamanetworkopen.2023.31078 37624596
    [Google Scholar]
  200. Singh G.K. Miller B.A. Hankey B.F. Edwards B.K. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000. Cancer 2004 101 5 1051 1057 10.1002/cncr.20467 15329915
    [Google Scholar]
  201. Miller K.D. Ortiz A.P. Pinheiro P.S. Bandi P. Minihan A. Fuchs H.E. Martinez Tyson D. Tortolero-Luna G. Fedewa S.A. Jemal A.M. Siegel R.L. Cancer statistics for the US Hispanic/Latino population, 2021. CA Cancer J. Clin. 2021 71 6 466 487 10.3322/caac.21695 34545941
    [Google Scholar]
  202. He J. Chen W.Q. Li N. Shen H.B. Li J. Wang Y. Li J. Tian J.H. Zhou B.S. China guideline for the screening and early detection of female breast cancer(2021, Beijing). Zhonghua Zhong Liu Za Zhi 2021 43 4 357 382 10.3760/cma.j.cn112152‑20210119‑00061 33902200
    [Google Scholar]
  203. Schünemann H.J. Lerda D. Quinn C. Follmann M. Alonso-Coello P. Rossi P.G. Lebeau A. Nyström L. Broeders M. Ioannidou-Mouzaka L. Duffy S.W. Borisch B. Fitzpatrick P. Hofvind S. Castells X. Giordano L. Canelo-Aybar C. Warman S. Mansel R. Sardanelli F. Parmelli E. Gräwingholt A. Saz-Parkinson Z. Breast cancer screening and diagnosis: A synopsis of the european breast guidelines. Ann. Intern. Med. 2020 172 1 46 56 10.7326/M19‑2125 31766052
    [Google Scholar]
/content/journals/ccdt/10.2174/0115680096369006250909091053
Loading
The Impact of Young Age on Breast Cancer Prognosis: A Systematic Review and Meta-Analysis
Bentham Science Publishers ; https://doi.org/10.2174/0115680096369006250909091053
/content/journals/ccdt/10.2174/0115680096369006250909091053
/content/journals/ccdt/10.2174/0115680096369006250909091053
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article. PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: disease-free survival (DFS) ; breast cancer ; prognoses ; pathological complete response (pCR) ; survival ; Young patients with breast cancer

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test